Vietnam recalls Pharmedic’s 0.9% sodium chloride eye drops over quality violation

The recalled batch carries the circulation registration number 893100060724, batch number 10370725, manufacturing date July 14, 2025, and expiry date January 14, 2028.

According to the Drug Administration, testing found the eye-drop solution did not meet required clarity standards.

Pharmedic’s Natri Clorid 0.9% eye and nasal drops contain sodium chloride and are marketed for eye and nasal rinsing, as supportive treatment for nasal congestion, runny nose, and allergic rhinitis.

The product is also advertised as suitable for newborns and is widely sold at pharmacies and hospitals in Vietnam.

The regulator ordered Pharmedic to halt sales and quarantine the affected batch, while reporting its distribution network to wholesalers and medical facilities.

The company must also notify all pharmacies, drugstore chains, and healthcare providers that received the recalled batch.

Pharmedic has been ordered to complete the recall and collection of the affected batch within 30 days from May 11.

The company must also handle the disposal of the recalled products, bear all recall and treatment costs, and compensate for damages in accordance with the law.

Wholesalers, retailers, and pharmacy chains were instructed to stop selling and distributing the affected batch, organize its recall, and return the products to suppliers.

Healthcare facilities and consumers were told to stop prescribing, dispensing, and using the recalled batch and return the products to the supplier.

The Drug Administration also directed provincial and municipal health departments to strengthen monitoring of medicines circulating on the market, with a focus on testing samples of the recalled product.